IMB-203

N/A

Report date: 2026/03/30 17:02:26

Base Information

Drug NameIMB-203
Drug Alias Namesuccinate prodrug (Imbira Pharmaceuticals)IMB-203
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionSuccinate dehydrogenase modulators
TargetsSuccinate dehydrogenase
Therapy Area/IndicationsMetabolism, Inborn Errors
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesImbria Pharmaceuticals Inc
China Registration ClassN/A

Develop Information

Active CompaniesImbria Pharmaceuticals Inc
Inactive CompaniesN/A
Active IndicationsMetabolism, Inborn Errors
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A